Assisted reproductive treatment (ART)
Women with MS who are having difficulty conceiving may benefit from fertility treatments . Indeed, use of ART appears to be rising among women with MS [2-4]. A Finnish study found that 4.9% of women with MS used ART (3/61) during the years 2003 to 2005, compared with 0.9% of women without MS (Medical birth register, n= 55,547) . A more recent evaluation from Spain reported that 14% of women with MS underwent ART (5/39) . Therefore the potential impact of ART is becoming an increasingly relevant consideration for women with MS [2-4].
While there is some concern that ART could increase risk of relapse, data is limited, conflicting and inconclusive [1,4-7]. Even less is known about other factors such as a potential rebound effect after withdrawal of MS therapy, stress associated with infertility, and hormone-induced immunological changes that may also play a role in MS activation .
Shortening the time between MS therapy discontinuation and ART, or continuing use of MS therapy such as the injectables during ART may help overcome a potentially increased risk of MS activity following ART [4,6,7].
- Hellwig H, Correale J. Clinical Immunology 2013; 149(2): 219-24. Return to content
- Jalkanen A et al. Mult Scler 2010; 16(8): 950-5. Return to content
- Cuello JP et al. Neurología 2017; 32(2): 92-8. Return to content
- Bove R et al. Mult Scler 2020; 26(11): 1410-19. Return to content
- Torkildsen O et al. Mult Scler Rel Disord 2018; 22: 38-40. Return to content
- Mainguy M et al. Neurology. 2022;10.1212/WNL.0000000000201027. Return to content
- Dobson R, Bove R M et al. Neurology. 2022;10.1212/WNL.0000000000201242. Return to content